The Europe foot and mouth disease (FMD) vaccine market size reached USD 105.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 231.5 Million by 2034, exhibiting a growth rate (CAGR) of 8.87% during 2026-2034.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2025
|
|
Forecast Years
|
2026-2034
|
|
Historical Years
|
2020-2025
|
| Market Size in 2025 | USD 105.3 Million |
| Market Forecast in 2034 | USD 231.5 Million |
| Market Growth Rate (2026-2034) | 8.87% |
Foot and mouth disease (FMD) refers to an animal disease that affects cattle, buffaloes, pigs, sheep, and numerous other wildlife species. This disease is caused by the virus belonging to the Aphthovirus genus of the Picornaviridae family. The global disparity between virus control and eradication has created the need for effective vaccination for the disease. This vaccine is an essential tool that is used to combat FMD while optimizing vaccine-based control programs.

To get more information on this market Request Sample
The Europe FMD vaccine market is primarily driven by the prevalence of FMD in the bordering countries of the European continent. The presence of two intergovernmental vaccine banks, namely the International Vaccine Bank (IVB) and the European Union Vaccine Bank (EUVB), is also propelling the growth of the market. These authorities either maintain a vaccine bank or have contracted commercial vaccine manufacturers to hold FMD vaccine and antigen on their behalf. Furthermore, as biosecurity of laboratories and vaccine production facilities is essential, the European Commission for the Control of Foot-and-Mouth Disease (EUFMD) has set detailed biosecurity aspects. Due to this, laboratories and producers in the EU have to comply with these standards to get approval under EU Directive 2003/85 to work with the FMD virus.
IMARC Group provides an analysis of the key trends in each segment of the Europe foot and mouth disease (FMD) vaccine market report, along with forecasts at the regional and country levels from 2026-2034. Our report has categorized the market based on animal type, vaccine type and distribution channel.
Breakup by Animal Type:
Breakup by Vaccine Type:
Breakup by Distribution Channel:

Access the comprehensive market breakdown Request Sample
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2034 |
| Units | Million USD |
| Segment Coverage | Animal Type, Vaccine Type, Distribution Channel, Country |
| Countries Covered | Turkey, Georgia, Armenia |
| Customization Scope | 10% Free Customization |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report: